The Journal of Immunology, Vol 146, Issue 7 2122-2129, Copyright © 1991 by American Association of Immunologists

ARTICLES

Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti- CD23 antibody prevents B lymphocyte proliferation and differentiation

HY Luo, H Hofstetter, J Banchereau and G Delespesse
University of Montreal, Notre-Dame Hospital, Research Center, Canada.

The possible role of CD23 in the activation of human B lymphocytes was systematically investigated by examining the effect of: 1) anti-CD23 mAb; 2) IgE or IgE-immune complexes and; 3) native or recombinant soluble CD23 of different m.w., on B cell proliferation. Intact anti- CD23 mAb or its F(ab')2 fragments inhibit the proliferation of tonsillar B lymphocytes costimulated with either Staphylococcus aureus Cowan I (SAC) or anti-IgM and IL-4. The antibody has no effect when IL- 2 or LMW-BCGF is used as the second stimulant. The response of IL-4- pretreated B cells (expressing high levels of CD23) to anti-IgM together with IL-2 or B cell-derived B cell growth factor is inhibited by anti-CD23 mAb, indicating that this antibody prevents B cell activation regardless of the B cell activators but provided that the density of CD23 on B cells is sufficient. Anti-CD23 mAb markedly inhibits DNA synthesis only when added during the first 12 h of the culture and has no effect on the ongoing proliferation of CD23-bearing B cell blasts (SAC induced and IL-4 supported or EBV transformed). Monovalent Fab fragments of anti-CD23 mAb are inactive unless they are used in tandem with goat anti-mouse Fab suggesting that the inhibition is due to cross-linking of surface CD23. Most interestingly, polymeric IgE or IgE-immune complexes have the same effect as anti-CD23 and moreover they inhibit IgM production by SAC and IL4-stimulated B cells. The inhibiting effect of IgE or of anti-CD23 mAb is not due to their neutralization of soluble CD23 because these failed to display B cell growth factor activity under various experimental conditions. It is concluded that IgE-immune complexes may regulate activation and differentiation of CD23-bearing surfaceIgM/surfaceIgD precursor B lymphocytes.

This article has been cited by other articles:

				G. M. E. Matta, S. Battaglio, C. DiBello, P. Napoli, C. Baldi, G. Ciccone, M. Coscia, M. Boccadoro, and M. Massaia Polyclonal Immunoglobulin E Levels Are Correlated with Hemoglobin Values and Overall Survival in Patients with Multiple Myeloma Clin. Cancer Res., September 15, 2007; 13(18): 5348 - 5354. [Abstract] [Full Text] [PDF]

				R. G. Hibbert, P. Teriete, G. J. Grundy, R. L. Beavil, R. Reljic, V. M. Holers, J. P. Hannan, B. J. Sutton, H. J. Gould, and J. M. McDonnell The structure of human CD23 and its interactions with IgE and CD21 J. Exp. Med., September 19, 2005; 202(6): 751 - 760. [Abstract] [Full Text] [PDF]

				I. I. Kuzin, J. E. Snyder, G. D. Ugine, D. Wu, S. Lee, T. Bushnell Jr, R. A. Insel, F. M. Young, and A. Bottaro Tetracyclines inhibit activated B cell function Int. Immunol., July 1, 2001; 13(7): 921 - 931. [Abstract] [Full Text] [PDF]

				M. Cernadas, G. T. De Sanctis, S. J. Krinzman, D. A. Mark, C. E. Donovan, J. A. Listman, L. Kobzik, H. Kikutani, D. C. Christiani, D. L. Perkins, et al. CD23 and Allergic Pulmonary Inflammation: Potential Role as an Inhibitor Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 1 - 8. [Abstract] [Full Text]

				L. A. Marshall, M. J. Hansbury, B. J. Bolognese, R. J. Gum, P. R. Young, and R. J. Mayer Inhibitors of the p38 Mitogen-Activated Kinase Modulate IL-4 Induction of Low Affinity IgE Receptor (CD23) in Human Monocytes J. Immunol., December 1, 1998; 161(11): 6005 - 6013. [Abstract] [Full Text] [PDF]

				O. Munoz, C. Brignone, N. Grenier-Brossette, J.-Y. Bonnefoy, and J.-L. Cousin Binding of Anti-CD23 Monoclonal Antibody to the Leucine Zipper Motif of Fcepsilon RII/CD23 on B Cell Membrane Promotes Its Proteolytic Cleavage. EVIDENCE FOR AN EFFECT ON THE OLIGOMER/MONOMER EQUILIBRIUM J. Biol. Chem., November 27, 1998; 273(48): 31795 - 31800. [Abstract] [Full Text] [PDF]